Markets / Mutual funds / Sectoral / Thematic

PGIM India Healthcare Fund - Regular Plan - Growth

NAVs of 8 Nov 2026

PGIM India Mutual Fund · Equity fund · Regular plan · Growth

Sectoral / ThematicRegular · GrowthRisk: Very High
NAV · 6 Nov 2026
₹12.1000 ▲ 0.75%
PGIM India Mutual Fund
Fund size₹118 crJuly - September 2026
1-month range₹11.11 – 12.10
1 year+20.04%rank 11 of 280
Expense ratio2.65%regular plan, a year
5 years–a year

What the fund does

The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there is no assurance that the investment objective of the scheme will be achieved. The Scheme does not guarantee/ indicate any returns.

BenchmarkBSE Healthcare TRI
Launched6 Dec 2024
Fund housePGIM India Mutual Fund
Fund managersAnandha Padmanabhan Anjeneyansince 6 Dec 2024Utsav Mehtasince 6 Dec 2024Vivek Sharmasince 6 Dec 2024Puneet Pal

NAV history

111212 2026-08-122026-08-252026-09-072026-09-212026-10-052026-10-162026-10-30

Returns

1 week
+3.33%avg 5.4%
1 month
+2.28%avg 2.9%
3 months
-0.33%avg -1.9%
6 months
+13.72%avg 3.1%
This year
+22.97%avg 3.2%
1 year
+20.04%avg 3.7% · #11/280

Bars: this plan; the thin mark is the Sectoral / Thematic average (regular plans, growth option). Over a year: yearly averages (CAGR). Past returns do not guarantee future returns. Information only, not investment advice.

Monthly returns (%)

YearJanFebMarAprMayJunJulAugSepOctNovDec
2024+1.6
2025-5.9-7.9+7.3+1.4+0.6+3.0+2.7-3.8-1.6+4.8+0.6-2.6
2026-5.1+7.5-4.6+6.4+3.9+6.8+5.7+3.4-4.0-1.3+3.3

Each month's change in NAV (the current month to the latest NAV).

What if you had invested?

Worked out from this plan's actual NAVs. SIP: invested on the first NAV of each month. Taxes and exit loads are not included. Past returns do not guarantee future returns. Information only, not investment advice.

Portfolio as on 30 Sept 2026

Stocks held3133 lines in all
Top 10 stocks57.2%of the fund
Short positions-0.1%sold through derivatives
Net equity94.8%long stocks and derivatives minus shorts

Where the money is

Equity 94.9%Cash & others 5.1%Short -0.1%

Sectors (stocks held)

Pharmaceuticals & Biotechnology
62.8%
Healthcare Services
24.6%
Chemicals & Petrochemicals
3.2%
Insurance
2.1%
Retailing
1.0%
Healthcare Equipment & Supplies
0.8%
IT - Services
0.4%

Changes since 31 Aug 2026

Share of fund30 Sept 202631 Aug 2026Change
Stocks held94.9%94.6%+0.31
Short positions-0.1%-0.3%+0.21
Cash & others5.1%5.4%-0.31
Top 10 stocks57.2%59.6%-2.45
Number of stocks31310
New stocks 2
  • Symbiotec Pharmalab Ltd.1.10%
  • Molbio Diagnostics Ltd.0.80%
Stocks sold off 2
  • Pfizer Ltd.was 2.12%
  • Dr Agarwal's Health Care Ltd.was 0.86%
Bought more 10
  • IPCA Laboratories Ltd.+1.41
  • Gland Pharma Ltd.+0.77
  • ICICI Lombard General Insurance Co. Ltd.+0.70
  • Dr Agarwal's Eye Hospital Ltd.+0.66
  • Zydus Lifesciences Ltd.+0.53
  • Lupin Ltd.+0.51
  • Dr. Lal Path Labs Ltd.+0.40
  • Fortis Healthcare Ltd.+0.36
  • Abbott India Ltd.+0.29
  • Lenskart Solutions Ltd.+0.28
Cut back 9
  • Rubicon Research Ltd.-1.02
  • Divi's Laboratories Ltd.-0.49
  • Sun Pharmaceutical Industries Ltd.-0.49
  • Manipal Health Enterprises Ltd.-0.44
  • Torrent Pharmaceuticals Ltd.-0.37
  • Neuland Laboratories Ltd.-0.35
  • Aster DM Quality Care Ltd.-0.33
  • Jupiter Life Line Hospitals Ltd.-0.31
  • Max Healthcare Institute Ltd.-0.25

Change is in percentage points. Bought more and cut back list stocks whose share of the fund moved by at least 0.25 points. A share can also move because the price changed, not only because the fund traded.

Stocks held 31

HoldingSector / type% of fund
Divi's Laboratories Ltd.
INE361B01024
Pharmaceuticals & Biotechnology10.36%
Sun Pharmaceutical Industries Ltd.
INE044A01036
Pharmaceuticals & Biotechnology10.25%
Torrent Pharmaceuticals Ltd.
INE685A01028
Pharmaceuticals & Biotechnology8.49%
Ajanta Pharma Ltd.
INE031B01049
Pharmaceuticals & Biotechnology4.96%
Max Healthcare Institute Ltd.
INE027H01010
Healthcare Services4.71%
Dr. Lal Path Labs Ltd.
INE600L01024
Healthcare Services4.33%
Mankind Pharma Ltd.
INE634S01028
Pharmaceuticals & Biotechnology4.04%
Manipal Health Enterprises Ltd.
INE459N01021
Healthcare Services3.68%
Navin Fluorine International Ltd.
INE048G01026
Chemicals & Petrochemicals3.24%
Abbott India Ltd.
INE358A01014
Pharmaceuticals & Biotechnology3.12%
Krishna Inst of Medical Sciences Ltd.
INE967H01025
Healthcare Services2.99%
Rubicon Research Ltd.
INE506V01022
Pharmaceuticals & Biotechnology2.99%
Neuland Laboratories Ltd.
INE794A01010
Pharmaceuticals & Biotechnology2.91%
Aster DM Quality Care Ltd.
INE914M01019
Healthcare Services2.56%
Sai Life Sciences Ltd
INE570L01029
Pharmaceuticals & Biotechnology2.54%
ICICI Lombard General Insurance Co. Ltd.
INE765G01017
Insurance2.10%
Cipla Ltd.
INE059A01026
Pharmaceuticals & Biotechnology2.04%
Zydus Lifesciences Ltd.
INE010B01027
Pharmaceuticals & Biotechnology2.04%
Lupin Ltd.
INE326A01037
Pharmaceuticals & Biotechnology1.93%
IPCA Laboratories Ltd.
INE571A01038
Pharmaceuticals & Biotechnology1.92%
Dr Agarwal's Eye Hospital Ltd.
INE934C01018
Healthcare Services1.86%
Anthem Biosciences Ltd.
INE0CZ201020
Pharmaceuticals & Biotechnology1.81%
Global Health Ltd.
INE474Q01031
Healthcare Services1.52%
Gland Pharma Ltd.
INE068V01023
Pharmaceuticals & Biotechnology1.50%
Jupiter Life Line Hospitals Ltd.
INE682M01020
Healthcare Services1.46%
Fortis Healthcare Ltd.
INE061F01013
Healthcare Services1.46%
Symbiotec Pharmalab Ltd.
INE899I01028
Pharmaceuticals & Biotechnology1.10%
Lenskart Solutions Ltd.
INE956O01016
Retailing0.99%
Molbio Diagnostics Ltd.
INE869T01028
Healthcare Equipment & Supplies0.80%
Orchid Pharma Ltd.
INE191A01027
Pharmaceuticals & Biotechnology0.79%
Sagility Ltd.
INE0W2G01015
IT - Services0.40%

Short positions 1

HoldingSector / type% of fund
Net Receivables / (Payables)–-0.13%

Debt, money market and cash 1

HoldingSector / type% of fund
Clearing Corporation of India Ltd.–5.24%

From the fund house's monthly portfolio (pgimindia.com), as on 30 Sept 2026. Percentages are of the fund's net assets; short positions are negative. Published about ten days after each month ends.

Risk

Volatility12.7%yearly, from daily NAVs
Worst fall-14.16%3 Jan 2025 → 28 Feb 2025
RiskometerVery HighVery High

Volatility: how much the NAV moves, as a yearly figure (higher = bumpier). Worst fall: the biggest drop from a high, in the NAV history we hold (from 13 Dec 2024).

Fund details

Fund size (average AUM, July - September 2026)₹118 cr across all plans · this plan ₹108 cr
Fund housePGIM India Mutual Fund
CategoryEquity · Sectoral / Thematic
PlanRegular
OptionGrowth
Expense ratio (TER)Direct 0.98% · Regular 2.65% (5 Nov 2026)
Exit loadFor Exits within 90 days from date of allotment of units: 0.50%; For Exits beyond 90 days from date of allotment of units: NIL.
Minimum investment₹5,000 · additional ₹1,000
Scheme code (AMFI)153040
ISININF663L01Z52
NAV date6 Nov 2026

Scheme details from the fund's scheme summary document filed with AMFI; expense ratios from AMFI's daily filings.

Other plans of this fund

PlanNAV1 year
Direct · Growth₹12.5000+22.07%
Regular · IDCW₹12.5000+22.07%
Regular · IDCW₹12.1000+20.04%

Top Sectoral / Thematic funds (regular plans)

Fund1 year3 years (a year)
Nippon India Taiwan Equity Fund+37.70%+40.44%
HDFC Defence Fund+19.63%+33.69%
HDFC Pharma and Healthcare Fund+26.81%+30.17%
SBI HEALTHCARE OPPORTUNITIES FUND+21.11%+24.39%
HDFC Transportation and Logistics Fund+8.74%+23.82%
UTI - Healthcare Fund+17.70%+23.50%
Mirae Asset Healthcare Fund+22.57%+23.40%
BANK OF INDIA MANUFACTURING & INFRASTRUCTURE FUND+16.15%+22.19%
PGIM India Healthcare Fund+20.04%–

All Sectoral / Thematic funds ranked › · Compare with others ›

← All mutual funds

Information only, not investment advice.

What is the NAV of PGIM India Healthcare Fund - Regular Plan - Growth today?

₹12.1000 as of 6 Nov 2026, from AMFI's official NAV data.

What are the returns of PGIM India Healthcare Fund - Regular Plan - Growth?

1 year: 20.04%

How does PGIM India Healthcare Fund rank in its category?

11 of 280 Sectoral / Thematic funds (regular plans, growth option) by 1-year return.

What is the difference between direct and regular plans?

Both invest in the same portfolio. Direct plans are bought straight from the fund house and pay no distributor commission, so their expenses are lower and their NAV grows slightly faster.